The tissue microarray test results in 139 patients with CRC indicated that both FOXO4 and APC2 were downregulated significantly in CRC tumor lesions than normal tissue adjacent to carcinoma (Figures 1C,D). The gene discussed is APC2; the disease is carcinoma.